semaglutide news A pilot program will cover weight-loss drugs for millions of Medicare enrollees for the first time beginning July 1. Read more about who's eligible and what medications are included at the link GLP‑1 Drugs May Be the

Recent efforts by Wegovy and Zepbound to pick up new indications to improve payer access have generally been a successful strategy but come with caveats at the payer level

Reseeding a microbiome is like planting a lawn

In humans and rodents, GIP infusion results in decreased levels of cross-linked C-terminal telopeptide of type I collagen (CTX-1) and increased levels of procollagen type I N-terminal propeptide (P1NP), regardless of whether blood glucose levels are normal or elevated [50,51,52]

Diclofenac is widely distributed in the body so that systemic bioavailability is only 50%, found in the highest concentrations in liver and kidney